{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:59:10Z","timestamp":1790139550849,"version":"4.0.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T00:00:00Z","timestamp":1402444800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0099907","type":"journal-article","created":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T20:47:17Z","timestamp":1402519637000},"page":"e99907","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["SHARP1 Suppresses Angiogenesis of Endometrial Cancer by Decreasing Hypoxia-Inducible Factor-1\u03b1 Level"],"prefix":"10.1371","volume":"9","author":[{"given":"Yun","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiting","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfen","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,6,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"R Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.pathol.2.010506.091905","article-title":"Endometrial carcinoma","volume":"2","author":"A Di Cristofano","year":"2007","journal-title":"Annu Rev Pathol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2165\/11631840-000000000-00000","article-title":"Medical therapy of endometrial cancer: current status and promising novel treatments","volume":"72","author":"EK Hill","year":"2012","journal-title":"Drugs"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1200\/JCO.2010.34.1578","article-title":"Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group","volume":"29","author":"AM Oza","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref5","first-page":"CD003915","article-title":"Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma","volume":"8","author":"CL Vale","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","article-title":"Angiogenesis in cancer, vascular, rheumatoid and other disease","volume":"1","author":"J Folkman","year":"1995","journal-title":"Nat Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/386671a0","article-title":"Mechanisms of angiogenesis","volume":"386","author":"W Risau","year":"1997","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"D Hanahan","year":"1996","journal-title":"Cell"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/sonc.2002.37263","article-title":"Role of angiogenesis in tumor growth and metastasis","volume":"29","author":"J Folkman","year":"2002","journal-title":"Semin Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc1093","article-title":"Tumorigenesis and the angiogenic switch","volume":"3","author":"G Bergers","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.semcancer.2009.05.003","article-title":"The angiogenic switch in carcinogenesis","volume":"19","author":"V Baeriswyl","year":"2009","journal-title":"Semin Cancer Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis","volume":"23","author":"DJ Hicklin","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1158\/0008-5472.CAN-13-0964","article-title":"The relationship between tumor blood flow, angiogenesis, tumor hypoxia, and aerobic glycolysis","volume":"73","author":"L Ostergaard","year":"2013","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12253-011-9413-8","article-title":"Immunohistochemical study of the angiogenetic network of VEGF, HIF1alpha, VEGFR-2 and endothelial nitric oxide synthase (eNOS) in human breast cancer","volume":"18","author":"M Kafousi","year":"2012","journal-title":"Pathol Oncol Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ygyno.2007.11.028","article-title":"Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas","volume":"108","author":"IH Ozbudak","year":"2008","journal-title":"Gynecol Oncol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","article-title":"Tumor angiogenesis","volume":"358","author":"RS Kerbel","year":"2008","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1006\/bbrc.2000.4133","article-title":"Molecular cloning and characterization of DEC2, a new member of basic helix-loop-helix proteins","volume":"280","author":"K Fujimoto","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"ref18","first-page":"925","article-title":"Transcriptional repression by the basic helix-loop-helix protein Dec2: multiple mechanisms through E-box elements","volume":"19","author":"K Fujimoto","year":"2007","journal-title":"Int J Mol Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0925-4773(02)00049-7","article-title":"Embryonic expression of mSharp-1\/mDEC2, which encodes a basic helix-loop-helix transcription factor","volume":"114","author":"S Azmi","year":"2002","journal-title":"Mech Dev"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"20098","DOI":"10.1074\/jbc.M210427200","article-title":"mSharp-1\/DEC2, a basic helix-loop-helix protein functions as a transcriptional repressor of E box activity and Stra13 expression","volume":"278","author":"S Azmi","year":"2003","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2443.2010.01381.x","article-title":"Anti-apoptotic effect of the basic helix-loop-helix (bHLH) transcription factor DEC2 in human breast cancer cells","volume":"15","author":"Y Liu","year":"2010","journal-title":"Genes Cells"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10549-010-1083-9","article-title":"The rexinoid bexarotene represses cyclin D1 transcription by inducing the DEC2 transcriptional repressor","volume":"128","author":"Y Li","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature11207","article-title":"SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors","volume":"487","author":"M Montagner","year":"2012","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2220\/biomedres.33.75","article-title":"BHLH transcription factor DEC2 regulates pro-apoptotic factor Bim in human oral cancer HSC-3 cells","volume":"33","author":"Y Wu","year":"2012","journal-title":"Biomed Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2443.2007.01153.x","article-title":"Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression","volume":"13","author":"F Sato","year":"2008","journal-title":"Genes Cells"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijgo.2009.02.010","article-title":"Revised FIGO staging for carcinoma of the endometrium","volume":"105","author":"W Creasman","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e41862","DOI":"10.1371\/journal.pone.0041862","article-title":"Overexpression of the DEC1 protein induces senescence in vitro and is related to better survival in esophageal squamous cell carcinoma","volume":"7","author":"Q Xu","year":"2012","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/1471-2407-10-307","article-title":"Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma","volume":"10","author":"LM Seeber","year":"2010","journal-title":"BMC Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e32709","DOI":"10.1371\/journal.pone.0032709","article-title":"MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1","volume":"7","author":"ZM Shi","year":"2012","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e67458","DOI":"10.1371\/journal.pone.0067458","article-title":"Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma","volume":"8","author":"T Yang","year":"2013","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/1471-2407-11-425","article-title":"MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo","volume":"11","author":"F Jiang","year":"2011","journal-title":"BMC Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"N Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm0603-677","article-title":"Regulation of angiogenesis by hypoxia: role of the HIF system","volume":"9","author":"CW Pugh","year":"2003","journal-title":"Nat Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1006\/gyno.2000.6056","article-title":"Expression of vascular endothelial growth factors (VEGF-A\/VEGF-1 and VEGF-C\/VEGF-2) in postmenopausal uterine endometrial carcinoma","volume":"80","author":"M Hirai","year":"2001","journal-title":"Gynecol Oncol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.1158\/1078-0432.CCR-07-1017","article-title":"Clinical and biological significance of vascular endothelial growth factor in endometrial cancer","volume":"13","author":"AA Kamat","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/gyno.2000.5802","article-title":"Prognostic significance of vascular endothelial growth factor and its receptors in endometrial carcinoma","volume":"77","author":"Y Yokoyama","year":"2000","journal-title":"Gynecol Oncol"},{"key":"ref37","first-page":"3525","article-title":"Bevacizumab therapy in patients with recurrent uterine neoplasms","volume":"27","author":"JD Wright","year":"2007","journal-title":"Anticancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1200\/JCO.2010.32.6397","article-title":"Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study","volume":"29","author":"C Aghajanian","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1039\/c1cs15032d","article-title":"Targeting tumour angiogenesis with small molecule inhibitors of hypoxia inducible factor","volume":"40","author":"IK Nordgren","year":"2011","journal-title":"Chem Soc Rev"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.bcp.2013.02.009","article-title":"Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1alpha\/VEGF signaling pathway in human bladder cancer cells","volume":"85","author":"MC Chen","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/path.2878","article-title":"Basic helix-loop-helix transcription factor DEC1 negatively regulates cyclin D1","volume":"224","author":"UK Bhawal","year":"2011","journal-title":"J Pathol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/embor.2008.207","article-title":"SHARP1\/DEC2 inhibits adipogenic differentiation by regulating the activity of C\/EBP","volume":"10","author":"NT Gulbagci","year":"2009","journal-title":"EMBO Rep"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e2762","DOI":"10.1371\/journal.pone.0002762","article-title":"Disturbed clockwork resetting in Sharp-1 and Sharp-2 single and double mutant mice","volume":"3","author":"MJ Rossner","year":"2008","journal-title":"PLoS One"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/BJ20031760","article-title":"Expression of the gene for Dec2, a basic helix-loop-helix transcription factor, is regulated by a molecular clock system","volume":"382","author":"H Hamaguchi","year":"2004","journal-title":"Biochem J"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"47014","DOI":"10.1074\/jbc.M204938200","article-title":"Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes","volume":"277","author":"K Miyazaki","year":"2002","journal-title":"J Biol Chem"},{"key":"ref46","first-page":"871","article-title":"Differential regulation of DEC2 among hypoxia-inducible genes in endometrial carcinomas","volume":"17","author":"M Yunokawa","year":"2007","journal-title":"Oncol Rep"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia-a key regulatory factor in tumour growth","volume":"2","author":"AL Harris","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1017\/S1462399409001173","article-title":"Targeting the hypoxia-inducible factor (HIF) pathway in cancer","volume":"11","author":"E Poon","year":"2009","journal-title":"Expert Rev Mol Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","article-title":"Cancer metastasis: building a framework","volume":"127","author":"GP Gupta","year":"2006","journal-title":"Cell"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1158\/1078-0432.CCR-10-1360","article-title":"Hypoxia and hypoxia-inducible factors: master regulators of metastasis","volume":"16","author":"X Lu","year":"2010","journal-title":"Clin Cancer Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0099907","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T08:59:22Z","timestamp":1540285162000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0099907"}},"subtitle":[],"editor":[{"given":"Irina U.","family":"Agoulnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,11]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0099907","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,11]]}}}